Evidence mapPaperPMID 16706569Full record

SynthesisPharmacoEconomics2006

Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.

Sylvia M C Vijgen, Mirjam Hoogendoorn, Caroline A Baan, G Ardine de Wit, Wien Limburg, Talitha L Feenstra

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in PharmacoEconomics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Cost effectiveness of type 2 diabetes screening: A systematic review.Medical journal of the Islamic Republic of Iran · 2016
    Article
  6. Article
  7. Article
  8. Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.International journal of environmental research and public health · 2010
    Review
  9. Review
  10. Exercise therapy in type 2 diabetes.Acta diabetologica · 2009
    Review
  11. Article
  12. The prevention of type 2 diabetes.Nature clinical practice. Endocrinology & metabolism · 2008 · on this map
    Review
  13. Article
  14. Hospital costs associated with pediatric burn injury.Journal of burn care & research : official publication of the American Burn Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sylvia M C VijgenDepartment for Prevention and Health Services Research, National Institute of Public Health and Environment (RIVM), Bilthoven, The Netherlands. sylvia.vijgen@rivm.nl
Mirjam Hoogendoorn
Caroline A Baan
G Ardine de Wit
Wien Limburg
Talitha L Feenstra
National Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A systematic review of the literature was conducted to give an overview of economic evaluations of preventive interventions in type 2 diabetes mellitus. The interventions were sorted by type of preventive intervention (primary, secondary or tertiary) and by category (e.g. education, medication for hypertension). Several databases were searched for studies published between January 1990 and May 2004 on the three types of preventive intervention. For each study selected, inclusion of specific components from a standardised list of items, including quality, was recorded in a database. Summary tables were generated based on the database.A number of conclusions were drawn from this review. The most important was that strict blood pressure control was a more cost-effective intervention than less strict control, as shown by six studies reporting cost savings to very low costs per life-year gained. Primary and secondary prevention of type 2 diabetes were also highly cost effective, but these results were based on very few studies. Medications to reduce weight and hyperglycaemia together were cost effective compared with conventional interventions. Finally, the separate results regarding medications to reduce weight, hyperglycaemia and hypercholesterolaemia varied enormously, thus no conclusion could be drawn and further economic analysis is required.

Indexed as

Health Care CostsCost-Benefit AnalysisDiabetes Mellitus, Type 2DietExerciseHumansHyperglycemiaHypertensionObesityPatient Education as TopicPreventive Health Services

Identifiers

PMID16706569
OpenAlexW1975137954

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.